HCPCS code lookup
HCPCS Level II
Q2041
Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Ask Rivvi
- Code
- Q2041
- Description
- Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
NDC crosswalk
- 71287-0119-01 Yescarta, Gilead Sciences, Inc.. Billable units per 11-digit NDC: 1.
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.